The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...

Doctors on Monday urged the U.S. Food and Drug Administration to issue warnings to pregnant women against the use of certain ...

The US Food and Drug Administration recently convened a panel of experts to examine a sensitive and increasingly urgent ...

On July 21, the US Food and Drug Administration (FDA) convened a 10-expert panel to determine whether women should be warned about the potential dangers to their baby if they take antidepressants like ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not easing — the nation’s depression rates.

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications like fluoxetine (Prozac), sertraline (Zoloft) and citalopram (Celexa), among ...

Drug makers are adding a notice to widely used antidepressants that babies of women who take the drugs late in pregnancy may experience jitteriness and other withdrawal symptoms, U.S. officials said.